Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study
Aim: Many Muslims with Type II diabetes (T2DM) fast during Ramadan, which can put them at increased risk of hypoglycemia. This sub-analysis of the global DIA-RAMADAN study assessed the effectiveness and safety of gliclazide modified release (MR) 60 mg in the Bangladeshi cohort. Materials & met...
Main Authors: | Mohammed Farid Uddin, Murshed Ahamed Khan, Shahjada Selim, Nusrat Sultana, Mohammad Abu Sayem, Mohammed Mahboob Iftekhar, Maruf Bin Habib, Nazma Akter, Shahjamal Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2024-01-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: |
Similar Items
-
A Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide Modified Release during Fasting in Gulf Cooperation Council Countries: An Analysis from the International DIA-RAMADAN Study
by: Mohamed Hassanein, et al.
Published: (2022-07-01) -
Fasting with diabetes during Ramadan: An updated review
by: Shahjada Selim, et al.
Published: (2023-04-01) -
Fasting with diabetes during Ramadan: An updated review
by: Shahjada Selim, et al.
Published: (2023-04-01) -
Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
by: I. V. Kononenko, et al.
Published: (2021-11-01) -
Ramadan fasting and diabetes
by: Mohsen Khoshniat, et al.
Published: (2013-02-01)